
via drugtargetreview.com
A group of researchers has found a new way to limit excessive immune responses, which may point in a new direction for research in and treatment of e.g. autoimmune diseases.
Researchers from Aarhus University Hospital and Aarhus University in Denmark in collaboration with researchers from Colorado in the United States have found a new way to treat the inflammation involved in chronic diseases such as psoriasis, asthma and HIV. A group of transmitter substances (cytokines) in the immune system, the so-called IL-1 family, has been shown to play an important role in many of these diseases by regulating the body’s immune responses.
Professor Charles A. Dinarello from University of Colorado Denver is also an honorary doctor at Aarhus University. He is an expert in regulation and transmission of these cytokines. He is primarily known for discovering the important cytokine IL-1(-?), which plays an important role in countless diseases. In collaboration with Charles Dinarello, the Danish researchers have investigated a more efficient way of reducing the effect of the IL-1 family and in this way improve treatment of chronic inflammatory diseases.
Previous research has often focused on blocking a single cytokine or signaling pathway at a time. However, many diseases and sequela are driven by more than one cytokine. This has caused researchers to wonder if it could be possible to block more important signaling pathways of the IL-1 family at the same time, and in this way make it possible to develop better treatments. The researchers try to find a broader anti-inflammatory treatment impacting several important cytokines at the same time, but also trying to avoid that this causes unintended side-effects.
In this study, the researchers have investigated if a receptor (IL-1R3), which is not just involved in the signaling of one but six different inflammatory cytokines in the IL-1 family, could be a possible target in the treatment of chronic inflammatory disease. Using an antibody to block the effect of IL-1R3, it was possible for the researchers to investigate the effects in both studies on cells and mice.
In this way, researchers could study some of the consequences of the blocking of this receptor on the immune system. At the same time, the researchers specifically studied the effect of blocking IL-1R3 in mice with either gout, acute allergic inflammation (asthma) or psoriasis.
– The experiments showed that it was possible to effectively block the receptor and reduce manifestation of diseases, which underlines the potentials in our new approach, says MD and PhD Jesper Falkesgaard Højen.
– Even though new questions arise as a consequences of these results, we have managed to describe a new and effective approach to block IL-1 family driven inflammation, and in this way we have possibly contributed with a new direction to study and treat chronic inflammatory conditions driven by the IL-1 family.
Learn more: Danish-American research presents new ways of developing treatment of chronic inflammation
The Latest on: Autoimmune diseases
[google_news title=”” keyword=”autoimmune diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Autoimmune diseases
- 'Every parent's worst nightmare': 13-year-old girl in Lake County diagnosed with rare autoimmune diseaseon March 24, 2023 at 8:42 pm
The 13-year-old now needs a wheelchair to get from one end of her neighborhood street to the other. Sign up for our N ...
- 'Every parent's worst nightmare': 13-year-old girl in Lake County contracts rare autoimmune diseaseon March 24, 2023 at 7:56 pm
The 13-year-old now needs a wheelchair to get from one end of her neighborhood street to the other. But just a few months ago, she was able to dance. That all changed when she contracted a rare ...
- Artificial sweetener could help combat autoimmune diseaseon March 24, 2023 at 7:30 pm
Exploring new ways by which diet can impact health and disease through a sweetener and the impact upon the immune system.
- Autoimmune Disease Diagnosis Market Size, Share, Revenue, Trends And Drivers For 2023-2032on March 24, 2023 at 2:21 pm
The Business Research Company's Autoimmune Disease Diagnosis Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032 ...
- 2023-2026 Autoimmune Diseases Treatment Market Size and Industry Share Analysison March 24, 2023 at 5:13 am
Mar 24, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The Global Autoimmune Diseases ...
- Global Fc Fusion Protein for Autoimmune Disease Market: Future Extrapolations and Emerging Updates for 2023-2027on March 23, 2023 at 11:13 pm
The Fc Fusion Protein for Autoimmune Disease market is highly competitive, with several top key players vying for market share. These players are constantly innovating and introducing new products to ...
- Growing Demand For Advanced Therapies Drives Autoimmune Disease Therapeutics Market Growthon March 23, 2023 at 8:06 am
Autoimmune Disease Therapeutics Market Growth PORTLAND, OREGON, UNITED STATES, March 23, 2023 /einpresswire.com / -- autoimmune diseases ...
- What Causes Autoimmune Diseases? Expert Weighs Inon March 22, 2023 at 5:14 am
An autoimmune disease develops when your immune system unintentionally attacks your body rather than defending it. Dr Gangarathna Krishna, MRCP (UK), and MRCP Rheumatology (UK) share the following ...
- Why autoimmune disease visibility in the workplace matterson March 21, 2023 at 4:31 pm
Ellen Rudolph, co-founder and CEO of WellTheory, shares how her autoimmune journey inspired her to find new solutions.
- What Is Celiac Disease?on March 21, 2023 at 7:38 am
Celiac disease is an autoimmune disease in which the body mistakenly attacks itself, damaging the lining in the intestine after ingesting gluten. People with celiac disease must avoid all gluten, a ...
via Bing News